Heron Craters on Q2 Figures
Heron Therapeutics, Inc. (NASDAQ: HRTX) shares swooned early Friday. The Cary, North Carolina-based concern, a commercial-stage biotechnology company, today announced financial results for the three months ended June…
Read more